Sponsor or institution
Clinical trials and research at Spyre Therapeutics, Inc.
As of November 12, 2026, Find a Trial lists 2 clinical trials run by Spyre Therapeutics, Inc. that are recruiting, at sites in 36 countries (most in Canada (2), United States (1), Argentina (1)). By phase: Phase 2 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 36Countries
All recruiting trials (2)
-
SPY072 in adults with moderate to severe hidradenitis suppurativa
This study tests whether SPY072 can help adults with moderate to severe hidradenitis suppurativa when added to their current care, compared with a placebo over 16 weeks.
-
Long-acting antibody treatments alone and in combinations for moderate to severe ulcerative colitis
This tests long-acting antibody medicines, given after an IV induction and then as under-the-skin maintenance, to see if they help adults with moderate to severe ulcerative colitis.
Quick answers
How many clinical trials run by Spyre Therapeutics, Inc. are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 36 countries. The most sites are in Canada (2 trials), United States (1 trial), Argentina (1 trial), Australia (1 trial), Austria (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.